中文 | English
Return
Total: 138 , 1/14
Show Home Prev Next End page: GO
MeSH:(Pancreatic Neoplasms/*drug therapy)

3.Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy.

Jaeyun YANG ; Taekyu LIM ; Taegyoon KIM ; Seungmoon HAN ; Sanghee LEE ; Huiseo KIM ; Jiwon LEE ; Seongyeong AHN

Korean Journal of Pancreas and Biliary Tract 2016;21(4):209-215

4.Long Term Complete Response of Unresectable Locally Advanced Pancreatic Cancer after CCRT and Gemcitabine Chemotherapy.

Jaeyun YANG ; Taekyu LIM ; Taegyoon KIM ; Seungmoon HAN ; Sanghee LEE ; Huiseo KIM ; Jiwon LEE ; Seongyeong AHN

Korean Journal of Pancreas and Biliary Tract 2016;21(4):209-215

5.Current status and future prospect of pharmacotherapy for pancreatic cancer.

Yun FANG ; Meng-Ru LAI ; Yu-Qing GE ; Guang-Ji ZHANG ; Ru-Bin CHENG

China Journal of Chinese Materia Medica 2019;44(8):1509-1516

6.Adjuvant Therapy of Pancreatic Cancer

Woo Hyun PAIK

Journal of Digestive Cancer Report 2019;7(1):5-7

7.Arginine metabolism: a potential target in pancreatic cancer therapy.

Jin-Shou YANG ; Cheng-Cheng WANG ; Jiang-Dong QIU ; Bo REN ; Lei YOU

Chinese Medical Journal 2020;134(1):28-37

8.Systemic Chemotherapy in Advanced Pancreatic Cancer.

Hee Seung LEE ; Seung Woo PARK

Gut and Liver 2016;10(3):340-347

9.Core signaling pathways and new therapeutic targets in pancreatic cancer.

Lei YOU ; Ge CHEN ; Yu-pei ZHAO

Chinese Medical Journal 2010;123(9):1210-1215

10.Role of Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Cancer.

Woo Jin LEE ; Sang Myung WOO

Korean Journal of Pancreas and Biliary Tract 2016;21(3):117-127

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 138 , 1/14 Show Home Prev Next End page: GO